A resolution designating July 20, 2022, as "Glioblastoma Awareness Day".

Bill 117 sres 614, also known as the resolution designating July 20, 2022, as "Glioblastoma Awareness Day," aims to bring attention to the devastating effects of glioblastoma, a rare and aggressive form of brain cancer. The resolution highlights the need for increased awareness, research, and support for individuals and families affected by this disease.

Glioblastoma is known for its high mortality rate and limited treatment options, making it a particularly challenging cancer to treat. By designating July 20th as Glioblastoma Awareness Day, the resolution seeks to raise awareness about the impact of this disease on patients and their loved ones, as well as the urgent need for more research and resources to improve outcomes for those affected.

The resolution emphasizes the importance of early detection, access to quality care, and ongoing support for individuals living with glioblastoma. It also recognizes the efforts of healthcare providers, researchers, and advocates working tirelessly to advance our understanding of this complex disease and develop more effective treatments. Overall, Bill 117 sres 614 serves as a call to action for increased awareness and support for individuals and families affected by glioblastoma. By designating July 20th as Glioblastoma Awareness Day, the resolution aims to shine a light on this devastating disease and inspire greater efforts to improve outcomes for those impacted by it.